Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma - Related Studies

Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

This study is ongoing, but not recruiting participants.

Study NCT00091676. Last updated on May 6, 2008. Information provided by Biovest International

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Non-Hodgkins Lymphoma

2	Additional conditions recognized in this trial
		Lymphoma
		Lymphoma, Follicular
		Lymphoma, Non-Hodgkin

3	More general conditions related to this trial
		Immune System Diseases
		Immunoproliferative Disorders
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		tumor specific immune response
		control vaccine

5	Sponsors listed in this trial
		Biovest International